The countdown to this event is over!
00
Days
00
Hours
00
Minutes
00
Seconds
Date & Time: Thursday, September 19, 2024, 17:30 - 19:00 PM | Apéro: 19:00 - 20:00 PM
Venue: Uranus, Building D, EPFL Innovation Park, Lausanne, Switzerland
Empowering Healthcare and Well-being Through Innovation
Join us for an empowering evening of innovation and entrepreneurship
In partnership with Women in Digital Switzerland (WDS) and powered by Innosuisse, this event at EPFL Innovation Park celebrates women's leadership in healthcare innovation and entrepreneurship. Our focus is on showcasing women entrepreneurs like Esmeralda Megally of Xsensio and Dr. Marie-Agnès Doucey of Calico Biosystems, who are at the forefront of MedTech and healthcare industries.
Hear from Esmeralda and Marie-Agnès as they share their journeys through the complex world of start-up innovation, highlighting their groundbreaking work in developing technologies that promise better health outcomes. Esmeralda's work with wearable biosensors and Marie-Agnès' advancements in cancer therapy are paving the way for future innovations in healthcare.
Join us for an empowering evening:
- Entrepreneurial challenges: Discuss the unique challenges and opportunities faced by women entrepreneurs in bringing these technologies to market.
- Empowerment through learning: Gain insights from leading women entrepreneurs who are shaping the future of healthcare.
- Technological innovations: Explore pioneering advancements from Xsensio’s wearable biosensors to Calico Biosystems' drug efficacy tests.
- Drive change: Learn how you can enter the world of entrepreneurship.
- Networking opportunities: Connect with like-minded professionals, entrepreneurs and aspiring entrepreneurs during our networking apéro.
Don't miss this opportunity to be inspired and to network with women leaders in entrepreneurship and innovation. Limited spots are available, so secure your place today!
Featured Speakers
Esmeralda Megally
Esmeralda is the CEO of Xsensio, a company she co-founded a few years ago. Prior to Xsensio, she had several years of experience as manager at Boston-based investment firm Commons Capital where she was in charge of screening investment opportunities in a partnership with the Bill and Melinda Gates Foundation. She earned her MBA at the Massachusetts Institute of Technology (MIT), a B.S. and M.S. in Economics from ULB, Belgium and an executive degree in management from EPFL.
Dr. Marie-Agnès Doucey
Over the past 15 years, Marie-Agnès has been leading the development of innovative translational programs spanning the disciplines of oncology, drug development, systems biology, mathematical modeling and nanotechnologies.
She has contributed to more than 55 scientific publications.